CARDIFF ONCOLOGY, INC. Net Income (Loss) Available to Common Stockholders, Basic
CARDIFF ONCOLOGY, INC. (CRDF) reported Net Income (Loss) Available to Common Stockholders, Basic of -$9.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$9.24M.
- CARDIFF ONCOLOGY, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$12.35M.
- CARDIFF ONCOLOGY, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$7.22M.
- CARDIFF ONCOLOGY, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$11.26M.
- CARDIFF ONCOLOGY, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$45.88M.
- CARDIFF ONCOLOGY, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$45.45M.
- CARDIFF ONCOLOGY, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$41.47M.
- CARDIFF ONCOLOGY, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$38.73M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 152 month | Net Income (Loss) Available to Common Stockholders, Basic 155 month | Net Income (Loss) Available to Common Stockholders, Basic 158 month | Net Income (Loss) Available to Common Stockholders, Basic 161 month | Net Income (Loss) Available to Common Stockholders, Basic 164 month | Net Income (Loss) Available to Common Stockholders, Basic 167 month | Net Income (Loss) Available to Common Stockholders, Basic 170 month | Net Income (Loss) Available to Common Stockholders, Basic 173 month | Net Income (Loss) Available to Common Stockholders, Basic 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.24M 10-Q · filed 2026-08-11 | -$21.59M 10-Q · filed 2026-08-11 | -$28.81M derived: sum of 3 quarters · filed 2026-08-11 | -$40.08M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2026-03-31 | -$12.35M 10-Q · filed 2026-05-14 | -$19.57M derived: sum of 2 quarters · filed 2026-05-14 | -$30.84M derived: sum of 3 quarters · filed 2026-05-14 | -$44.79M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-12-31 | -$7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$18.49M derived: sum of 2 quarters · filed 2026-02-24 | -$32.44M derived: sum of 3 quarters · filed 2026-08-11 | -$45.88M 10-K · filed 2026-02-24 | |||||||||||||
| 2025-09-30 | -$11.26M 10-Q · filed 2025-11-06 | -$25.21M derived: sum of 2 quarters · filed 2026-08-11 | -$38.65M 10-Q · filed 2025-11-06 | -$50.45M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-06-30 | -$13.95M 10-Q · filed 2026-08-11 | -$27.39M 10-Q · filed 2026-08-11 | -$39.18M derived: sum of 3 quarters · filed 2026-08-11 | -$51.04M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-03-31 | -$13.44M 10-Q · filed 2026-05-14 | -$25.23M derived: sum of 2 quarters · filed 2026-05-14 | -$37.09M derived: sum of 3 quarters · filed 2026-05-14 | -$48.88M derived: sum of 4 quarters · filed 2026-05-14 | |||||||||||||
| 2024-12-31 | -$11.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$23.65M derived: sum of 2 quarters · filed 2026-02-24 | -$35.44M derived: sum of 3 quarters · filed 2026-02-24 | -$45.45M 10-K · filed 2026-02-24 | |||||||||||||
| 2024-09-30 | -$11.86M 10-Q · filed 2025-11-06 | -$23.64M derived: sum of 2 quarters · filed 2025-11-06 | -$33.66M 10-Q · filed 2025-11-06 | -$43.01M derived: sum of 4 quarters · filed 2025-11-06 | |||||||||||||
| 2024-06-30 | -$11.78M 10-Q · filed 2025-07-29 | -$21.80M 10-Q · filed 2025-07-29 | -$31.14M derived: sum of 3 quarters · filed 2025-07-29 | -$40.88M derived: sum of 4 quarters · filed 2025-07-29 | |||||||||||||
| 2024-03-31 | -$10.02M 10-Q · filed 2025-05-08 | -$19.36M derived: sum of 2 quarters · filed 2025-05-08 | -$29.10M derived: sum of 3 quarters · filed 2025-05-08 | -$40.25M derived: sum of 4 quarters · filed 2025-05-08 | |||||||||||||
| 2023-12-31 | -$9.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$19.08M derived: sum of 2 quarters · filed 2025-02-27 | -$30.24M derived: sum of 3 quarters · filed 2025-02-27 | -$41.47M 10-K · filed 2025-02-27 | |||||||||||||
| 2023-09-30 | -$9.74M 10-Q · filed 2024-11-07 | -$20.89M derived: sum of 2 quarters · filed 2024-11-07 | -$32.12M 10-Q · filed 2024-11-07 | -$40.83M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||||
| 2023-06-30 | -$11.16M 10-Q · filed 2024-08-08 | -$22.39M 10-Q · filed 2024-08-08 | -$31.09M derived: sum of 3 quarters · filed 2024-08-08 | -$39.66M derived: sum of 4 quarters · filed 2024-08-08 | |||||||||||||
| 2023-03-31 | -$11.23M 10-Q · filed 2024-05-02 | -$19.93M derived: sum of 2 quarters · filed 2024-05-02 | -$28.51M derived: sum of 3 quarters · filed 2024-05-02 | -$38.96M derived: sum of 4 quarters · filed 2024-05-02 | |||||||||||||
| 2022-12-31 | -$8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$17.28M derived: sum of 2 quarters · filed 2024-02-29 | -$27.73M derived: sum of 3 quarters · filed 2024-02-29 | -$38.73M 10-K · filed 2024-02-29 | |||||||||||||
| 2022-09-30 | -$8.58M 10-Q · filed 2023-11-02 | -$19.03M derived: sum of 2 quarters · filed 2023-11-02 | -$30.02M 10-Q · filed 2023-11-02 | -$39.47M derived: sum of 4 quarters · filed 2023-11-02 | |||||||||||||
| 2022-06-30 | -$10.45M 10-Q · filed 2023-08-09 | -$21.45M 10-Q · filed 2023-08-09 | -$30.90M derived: sum of 3 quarters · filed 2023-08-09 | -$37.81M derived: sum of 4 quarters · filed 2023-08-09 | |||||||||||||
| 2022-03-31 | -$11.00M 10-Q · filed 2023-05-04 | -$20.45M derived: sum of 2 quarters · filed 2023-05-04 | -$27.37M derived: sum of 3 quarters · filed 2023-05-04 | -$34.13M derived: sum of 4 quarters · filed 2023-05-04 | |||||||||||||
| 2021-12-31 | -$9.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$16.37M derived: sum of 2 quarters · filed 2023-03-02 | -$23.13M derived: sum of 3 quarters · filed 2023-03-02 | -$28.32M 10-K · filed 2023-03-02 | |||||||||||||
| 2021-09-30 | -$6.92M 10-Q · filed 2022-11-03 | -$13.68M derived: sum of 2 quarters · filed 2022-11-03 | -$18.87M 10-Q · filed 2022-11-03 | -$25.47M derived: sum of 4 quarters · filed 2022-11-03 | |||||||||||||
| 2021-06-30 | -$6.76M 10-Q · filed 2022-08-04 | -$11.95M 10-Q · filed 2022-08-04 | -$18.55M derived: sum of 3 quarters · filed 2022-08-04 | -$23.05M derived: sum of 4 quarters · filed 2022-08-04 | |||||||||||||
| 2021-03-31 | -$5.18M 10-Q · filed 2022-05-05 | -$11.79M derived: sum of 2 quarters · filed 2022-05-05 | -$16.29M derived: sum of 3 quarters · filed 2022-05-05 | -$23.69M derived: sum of 4 quarters · filed 2022-05-05 | |||||||||||||
| 2020-12-31 | -$6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$11.11M derived: sum of 2 quarters · filed 2022-02-24 | -$18.50M derived: sum of 3 quarters · filed 2022-02-24 | -$22.60M 10-K · filed 2022-02-24 | -$22.60M 10-K · filed 2021-02-25 | ||||||||||||
| 2020-09-30 | -$4.50M 10-Q · filed 2021-11-04 | -$4.50M 10-Q · filed 2020-11-05 | -$11.90M derived: sum of 2 quarters · filed 2021-11-04 | -$15.99M 10-Q · filed 2021-11-04 | -$15.99M 10-Q · filed 2020-11-05 | -$20.24M derived: sum of 4 quarters · filed 2021-11-04 | |||||||||||
| 2020-06-30 | -$7.40M 10-Q · filed 2021-08-05 | -$7.40M 10-Q · filed 2020-08-11 | -$11.49M 10-Q · filed 2021-08-05 | -$11.49M 10-Q · filed 2020-08-11 | -$15.74M derived: sum of 3 quarters · filed 2021-08-05 | -$19.89M derived: sum of 4 quarters · filed 2021-08-05 | |||||||||||
| 2020-03-31 | -$4.09M 10-Q · filed 2021-05-06 | -$4.09M 10-Q · filed 2020-05-07 | -$8.34M derived: sum of 2 quarters · filed 2021-05-06 | -$12.49M derived: sum of 3 quarters · filed 2021-05-06 | -$16.62M derived: sum of 4 quarters · filed 2021-05-06 | ||||||||||||
| 2019-12-31 | -$4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$8.40M derived: sum of 2 quarters · filed 2021-02-25 | -$12.53M derived: sum of 3 quarters · filed 2021-02-25 | -$16.71M 10-K · filed 2021-02-25 | |||||||||||||
| 2019-09-30 | -$4.15M 10-Q · filed 2020-11-05 | -$8.28M derived: sum of 2 quarters · filed 2020-11-05 | -$12.46M 10-Q · filed 2020-11-05 | -$16.62M derived: sum of 4 quarters · filed 2020-11-05 | |||||||||||||
| 2019-06-30 | -$4.13M 10-Q · filed 2020-08-11 | -$8.31M 10-Q · filed 2020-08-11 | -$12.48M derived: sum of 3 quarters · filed 2020-08-11 | -$16.25M derived: sum of 4 quarters · filed 2020-08-11 | |||||||||||||
| 2019-03-31 | -$4.18M 10-Q · filed 2020-05-07 | -$8.34M derived: sum of 2 quarters · filed 2020-05-07 | -$12.12M derived: sum of 3 quarters · filed 2020-05-07 | -$18.64M derived: sum of 4 quarters · filed 2020-05-07 | |||||||||||||
| 2018-12-31 | -$4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$7.94M derived: sum of 2 quarters · filed 2020-02-27 | -$14.46M derived: sum of 3 quarters · filed 2020-02-27 | -$19.25M 10-K · filed 2020-02-27 | |||||||||||||
| 2018-09-30 | -$3.78M 10-Q · filed 2019-11-07 | -$10.30M derived: sum of 2 quarters · filed 2019-11-07 | -$15.09M 10-Q · filed 2019-11-07 | -$17.67M derived: sum of 4 quarters · filed 2019-11-07 | |||||||||||||
| 2018-06-30 | -$6.52M 10-Q · filed 2019-08-08 | -$11.31M 10-Q · filed 2019-08-08 | -$13.89M derived: sum of 3 quarters · filed 2019-08-08 | -$18.19M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||||||
| 2018-03-31 | -$4.79M 10-Q · filed 2019-05-07 | -$7.37M derived: sum of 2 quarters · filed 2019-05-07 | -$11.67M derived: sum of 3 quarters · filed 2019-05-07 | -$19.72M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||||||
| 2017-12-31 | -$2.58M 10-K · filed 2018-02-26 | -$6.87M derived: sum of 2 quarters · filed 2018-11-07 | -$14.93M derived: sum of 3 quarters · filed 2018-11-07 | -$24.93M 10-K · filed 2019-03-06 | |||||||||||||
| 2017-09-30 | -$4.30M 10-Q · filed 2018-11-07 | -$12.35M derived: sum of 2 quarters · filed 2018-11-07 | -$22.36M 10-Q · filed 2018-11-07 | -$30.91M derived: sum of 4 quarters · filed 2018-11-07 | |||||||||||||
| 2017-06-30 | -$8.05M 10-Q · filed 2018-08-03 | -$18.06M 10-Q · filed 2018-08-03 | -$26.61M derived: sum of 3 quarters · filed 2018-08-03 | -$36.81M derived: sum of 4 quarters · filed 2018-08-03 | |||||||||||||
| 2017-03-31 | -$10.01M 10-Q · filed 2018-05-08 | -$18.56M derived: sum of 2 quarters · filed 2018-05-08 | -$28.76M derived: sum of 3 quarters · filed 2018-05-08 | -$38.96M derived: sum of 4 quarters · filed 2018-05-08 | |||||||||||||
| 2016-12-31 | -$8.55M 10-K · filed 2018-02-26 | -$18.75M derived: sum of 2 quarters · filed 2018-02-26 | -$28.96M derived: sum of 3 quarters · filed 2018-02-26 | -$39.23M 10-K · filed 2018-02-26 | |||||||||||||
| 2016-09-30 | -$10.20M 10-K · filed 2018-02-26 | -$10.20M 10-Q · filed 2016-11-09 | -$20.41M derived: sum of 2 quarters · filed 2018-02-26 | -$30.67M 10-Q · filed 2017-11-09 | -$38.06M derived: sum of 4 quarters · filed 2018-02-26 | ||||||||||||
| 2016-06-30 | -$10.21M 10-K · filed 2018-02-26 | -$10.21M 10-Q · filed 2016-08-04 | -$20.48M 10-Q · filed 2017-08-09 | -$27.86M derived: sum of 3 quarters · filed 2018-02-26 | -$30.61M derived: sum of 4 quarters · filed 2018-02-26 | ||||||||||||
| 2016-03-31 | -$10.27M 10-K · filed 2018-02-26 | -$10.27M 10-Q · filed 2016-05-10 | -$17.66M derived: sum of 2 quarters · filed 2018-02-26 | -$20.40M derived: sum of 3 quarters · filed 2018-02-26 | -$30.58M derived: sum of 4 quarters · filed 2018-02-26 | ||||||||||||
| 2015-12-31 | -$7.39M 10-K · filed 2017-03-15 | -$10.13M derived: sum of 2 quarters · filed 2017-03-15 | -$20.32M derived: sum of 3 quarters · filed 2017-03-15 | -$27.50M 10-K · filed 2017-03-15 | |||||||||||||
| 2015-09-30 | -$2.74M 10-K · filed 2017-03-15 | -$2.74M 10-Q · filed 2015-11-09 | -$12.93M derived: sum of 2 quarters · filed 2017-03-15 | -$20.11M 10-Q · filed 2016-11-09 | -$24.80M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||||
| 2015-06-30 | -$10.19M 10-K · filed 2017-03-15 | -$10.19M 10-Q · filed 2015-08-10 | -$17.37M 10-Q · filed 2016-08-04 | -$22.05M derived: sum of 3 quarters · filed 2017-03-15 | -$27.44M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||||
| 2015-03-31 | -$7.18M 10-K · filed 2017-03-15 | -$7.18M 10-Q · filed 2015-05-05 | -$11.87M derived: sum of 2 quarters · filed 2017-03-15 | -$17.25M derived: sum of 3 quarters · filed 2017-03-15 | -$18.33M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||||
| 2014-12-31 | -$4.69M 10-K · filed 2016-03-10 | -$10.07M derived: sum of 2 quarters · filed 2016-03-10 | -$11.15M derived: sum of 3 quarters · filed 2016-03-10 | -$14.35M 10-K · filed 2017-03-15 | |||||||||||||
| 2014-09-30 | -$5.38M 10-K · filed 2016-03-10 | -$5.38M 10-Q · filed 2014-11-06 | -$6.46M derived: sum of 2 quarters · filed 2016-03-10 | -$9.66M 10-Q · filed 2015-11-09 | -$10.70M derived: sum of 4 quarters · filed 2016-03-10 | ||||||||||||
| 2014-06-30 | -$1.08M 10-K · filed 2016-03-10 | -$1.08M 10-Q · filed 2014-08-07 | -$4.28M 10-Q · filed 2015-08-10 | -$5.32M derived: sum of 3 quarters · filed 2016-03-10 | -$9.72M derived: sum of 4 quarters · filed 2016-03-10 | ||||||||||||
| 2014-03-31 | -$3.20M 10-K · filed 2016-03-10 | -$3.20M 10-Q · filed 2014-05-12 | -$4.24M derived: sum of 2 quarters · filed 2016-03-10 | -$8.64M derived: sum of 3 quarters · filed 2016-03-10 | -$13.92M derived: sum of 4 quarters · filed 2016-03-10 | -$70.24M 10-Q · filed 2014-05-12 | |||||||||||
| 2013-12-31 | -$1.04M 10-K · filed 2015-03-12 | -$5.45M derived: sum of 2 quarters · filed 2015-03-12 | -$10.72M derived: sum of 3 quarters · filed 2015-03-12 | -$11.84M 10-K · filed 2016-03-10 | -$67.04M 10-K · filed 2014-03-17 | ||||||||||||
| 2013-09-30 | -$4.41M 10-K · filed 2015-03-12 | -$4.41M 10-Q · filed 2013-11-14 | -$9.69M derived: sum of 2 quarters · filed 2015-03-12 | -$10.80M 10-Q · filed 2014-11-06 | -$17.14M derived: sum of 4 quarters · filed 2015-03-12 | -$66.01M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | -$5.28M 10-K · filed 2015-03-12 | -$5.28M 10-Q · filed 2013-08-14 | -$6.40M 10-Q · filed 2014-08-07 | -$12.73M derived: sum of 3 quarters · filed 2015-03-12 | -$13.39M derived: sum of 4 quarters · filed 2015-03-12 | -$61.60M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | -$1.12M 10-K · filed 2015-03-12 | -$1.12M 10-Q · filed 2013-05-14 | -$7.45M derived: sum of 2 quarters · filed 2015-03-12 | -$8.11M derived: sum of 3 quarters · filed 2015-03-12 | -$11.55M derived: sum of 4 quarters · filed 2015-03-12 | -$56.32M 10-Q · filed 2013-05-14 | |||||||||||
| 2012-12-31 | -$6.34M 10-K · filed 2014-03-17 | -$7.00M derived: sum of 2 quarters · filed 2014-03-17 | -$10.43M derived: sum of 3 quarters · filed 2014-03-17 | -$11.60M 10-K · filed 2015-03-12 | -$55.20M 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | -$660.00K 10-K · filed 2014-03-17 | -$659.78K 10-Q · filed 2012-11-14 | -$4.10M derived: sum of 2 quarters · filed 2014-03-17 | -$5.27M 10-Q · filed 2013-11-14 | -$6.52M derived: sum of 4 quarters · filed 2014-03-17 | -$48.87M 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | -$3.44M 10-K · filed 2014-03-17 | -$3.44M 10-Q · filed 2012-08-14 | -$4.61M 10-Q · filed 2013-08-14 | -$5.86M derived: sum of 3 quarters · filed 2014-03-17 | -$5.87M derived: sum of 4 quarters · filed 2014-03-17 | -$48.21M 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | -$1.17M 10-K · filed 2014-03-17 | -$1.17M 10-Q · filed 2012-05-15 | -$2.43M derived: sum of 2 quarters · filed 2014-03-17 | -$2.43M derived: sum of 3 quarters · filed 2014-03-17 | -$2.89M derived: sum of 4 quarters · filed 2014-03-17 | -$44.77M 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$1.26M derived: sum of 2 quarters · filed 2014-03-17 | -$1.72M derived: sum of 3 quarters · filed 2014-03-17 | -$2.28M 10-K · filed 2014-03-17 | |||||||||||||
| 2011-09-30 | -$291.00 10-Q · filed 2012-11-14 | -$459.01K derived: sum of 2 quarters · filed 2012-11-14 | -$1.02M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2011-06-30 | -$458.72K 10-Q · filed 2012-08-14 | -$1.02M 10-Q · filed 2012-08-14 | |||||||||||||||
| 2011-03-31 | -$561.55K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |